二氢埃托啡

Dihydroetorphine

未知生产厂商

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

适应症

本品仅限用于创伤、手术后及诊断明确的各种剧烈疼痛的止痛，包括对吗啡或哌替啶无效者。

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Dihydroetorphine for the provision of pain relief and anaesthesia
US 10898479 B2申请人: EURO CELTIQUE SA优先权: 2013
CN
US
2 件公开
Water-soluble medicine sublingual-medicating formulation
CN 1676130 A申请人: WANQUAN YANGGUANG PHARMACEUTIC优先权: 2004
CN
Compound injection of Xylazine, and preparation technique
CN 1957918 A申请人: YAN ZHANGNIAN优先权: 2006
CN
二氢埃托啡及其制备
CN 104119349 B申请人: 欧洲凯尔特公司优先权: 2008
CN
Chinese medicinal capsules for rehabilitation, and preparation process thereof
CN 102416136 A申请人: TIANHUA LI优先权: 2011
CN
Chinese medical drug abstinence tablet and preparation process thereof
CN 102389556 A申请人: TIANHUA LI优先权: 2011
CN
Chinese medicinal syrup for stopping drug addiction and preparation process thereof
CN 102423448 A申请人: TIANHUA LI优先权: 2011
CN
Transdermal delivery system
- CN 108025077 A
  申请人: EURO CELTIQUE SA优先权: 2015
  CN
- CN 108136028 A
  申请人: EURO CELTIQUE SA优先权: 2015
  CN
一种吗啡衍生物二氢埃托啡的合成方法
CN 114105875 B申请人: 四川大学优先权: 2021
CN